Amanat Acquisition Corp (AMAN) News
Follow Amanat Acquisition Corp (AMAN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Corxel to Go Public in US Through SPAC Transaction
MNA | Oct 26, 2026, 10:53 AM UTC
M
Corxel to Go Public Through Amanat Acquisition With $300 Million Investment
Corxel Pharmaceuticals plans to merge with blank-check company Amanat Acquisition to go public. The combination is backed by an oversubscribed $300 million private investment from healthcare funds.
MNA | Oct 26, 2026, 10:45 AM UTC
M
Corxel US, Amanat Acquisition Agree to Business Combination
Corxel US and Amanat Acquisition Corp announced a definitive business combination agreement to create a publicly listed obesity-focused biopharmaceutical company.
MNA | Oct 26, 2026, 10:23 AM UTC
M
Amanat Transaction Includes PIPE Commitments for About $300M in Gross Proceeds
The transaction includes commitments for a concurrent, oversubscribed PIPE and is expected to generate about $300 million in total gross proceeds, in addition to about $75 million held in Amanat’s trust account.
MNA | Oct 26, 2026, 10:04 AM UTC
M
Corxel US and Amanat Acquisition Corp Agree to Business Combination
The companies announced a definitive business combination agreement to create a publicly listed obesity-focused biopharmaceutical company.
MNA | Oct 26, 2026, 10:00 AM UTC